Enovis to Participate in Upcoming Investor Conferences
Enovis (NYSE: ENOV), a medical technology growth company, has announced its participation in three upcoming investor conferences:
- Canaccord Genuity 44th Annual Growth Conference on August 13th
- Wells Fargo Healthcare Conference on September 5th
- Baird 2024 Global Healthcare Conference on September 11th
The company's management team, including CFO Ben Berry and CEO Matt Trerotola, will participate in fireside chats at these events. Live audio webcasts and replays will be available on Enovis' website under the Investors tab. Enovis is dedicated to developing clinically differentiated solutions for better patient outcomes and improved workflows in orthopedics and beyond.
Enovis (NYSE: ENOV), un'azienda in crescita nel settore della tecnologia medica, ha annunciato la sua partecipazione a tre prossime conferenze per investitori:
- 44ª Conferenza Annuale sulla Crescita di Canaccord Genuity il 13 agosto
- Conferenza sulla Sanità di Wells Fargo il 5 settembre
- Conferenza Globale sulla Sanità di Baird nel 2024 il 11 settembre
Il team di gestione dell'azienda, incluso il CFO Ben Berry e il CEO Matt Trerotola, parteciperà a discussioni informali durante questi eventi. Le trasmissioni audio in diretta e le registrazioni saranno disponibili sul sito web di Enovis sotto la sezione Investitori. Enovis è dedicata allo sviluppo di soluzioni clinicamente differenziate per migliorare gli esiti per i pazienti e ottimizzare i flussi di lavoro in ortopedia e oltre.
Enovis (NYSE: ENOV), una empresa de crecimiento en tecnología médica, ha anunciado su participación en tres próximas conferencias para inversores:
- 44ª Conferencia Anual de Crecimiento de Canaccord Genuity el 13 de agosto
- Conferencia de Atención Médica de Wells Fargo el 5 de septiembre
- Conferencia Global de Atención Médica de Baird 2024 el 11 de septiembre
El equipo de gestión de la empresa, incluido el CFO Ben Berry y el CEO Matt Trerotola, participará en charlas informales en estos eventos. Las transmisiones de audio en vivo y las repeticiones estarán disponibles en el sitio web de Enovis en la pestaña Inversores. Enovis se dedica a desarrollar soluciones clínicamente diferenciadas para mejorar los resultados de los pacientes y optimizar los flujos de trabajo en ortopedia y más allá.
에노비스(뉴욕증권거래소: ENOV)는 의료 기술 성장 기업으로, 다가오는 세 가지 투자자 회의에 참여할 것이라고 발표했습니다:
- 카나코드 제너시티 제44회 연례 성장 컨퍼런스 8월 13일
- 웰스파고 헬스케어 컨퍼런스 9월 5일
- 베어드 2024 글로벌 헬스케어 컨퍼런스 9월 11일
회사의 관리 팀, 즉 CFO 벤 베리와 CEO 매트 트레로톨라가 이러한 이벤트에서 화로를 둘러싼 대화에 참여합니다. 실시간 오디오 웹캐스트와 재방송은 에노비스 웹사이트의 투자자 탭에서 확인할 수 있습니다. 에노비스는 환자 결과 개선과 정형외과를 비롯한 다양한 분야에서 향상된 워크플로우를 위한 임상 차별화 솔루션 개발에 전념하고 있습니다.
Enovis (NYSE: ENOV), une entreprise en croissance dans le secteur de la technologie médicale, a annoncé sa participation à trois conférences pour investisseurs à venir :
- 44ème Conférence Annuelle sur la Croissance de Canaccord Genuity le 13 août
- Conférence sur les Soins de Santé de Wells Fargo le 5 septembre
- Conférence Mondiale sur les Soins de Santé de Baird en 2024 le 11 septembre
L'équipe de direction de l'entreprise, y compris le CFO Ben Berry et le CEO Matt Trerotola, participera à des discussions informelles lors de ces événements. Des webcasts audio en direct et des rediffusions seront disponibles sur le site Web d'Enovis dans l'onglet Investisseurs. Enovis est dédiée au développement de solutions cliniquement différenciées pour améliorer les résultats des patients et optimiser les flux de travail en orthopédie et au-delà.
Enovis (NYSE: ENOV), ein wachstumsorientiertes Unternehmen im Bereich Medizintechnologie, hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen angekündigt:
- 44. jährliche Wachstums-Konferenz von Canaccord Genuity am 13. August
- Wells Fargo Healthcare Conference am 5. September
- Baird 2024 Global Healthcare Conference am 11. September
Das Management-Team des Unternehmens, einschließlich CFO Ben Berry und CEO Matt Trerotola, wird an informellen Gesprächen bei diesen Veranstaltungen teilnehmen. Live-Audio-Webcasts und Wiederholungen sind auf der Website von Enovis unter dem Reiter Investoren verfügbar. Enovis hat sich der Entwicklung klinisch differenzierter Lösungen verschrieben, um bessere Patientenresultate und optimierte Arbeitsabläufe in der Orthopädie und darüber hinaus zu erreichen.
- None.
- None.
Wilmington, DE, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:
- Canaccord Genuity 44th Annual Growth Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Tuesday, August 13th at 2:00 p.m. Eastern Time.
- Wells Fargo Healthcare Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Thursday, September 5th at 11:00 a.m. Eastern Time.
- Baird 2024 Global Healthcare Conference: Matt Trerotola, Chair, and Chief Executive Officer, will participate in a fireside chat on Wednesday, September 11th at 12:50 p.m. Eastern Time.
A link to the live audio webcasts, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
+1-917-734-7450
investorrelations@enovis.com
FAQ
When is Enovis (ENOV) participating in the Canaccord Genuity 44th Annual Growth Conference?
Who will represent Enovis (ENOV) at the Wells Fargo Healthcare Conference?
What time is Enovis (ENOV) scheduled for the Baird 2024 Global Healthcare Conference?
How can investors access the webcasts of Enovis (ENOV) conference presentations?
What is the stock symbol for Enovis ?
